Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Sanovas, a Bay-Area medical device maker, will start a...
Deals and Financings
BGI Genomics, the...
QIAGEN (Suzhou) Translational Medicine, a China precision...
CMAB Biopharma completed a $38 million Series A funding...
Deals and Financings
Perennial Real Estate of...
CMAB Biopharma of Suzhou announced a Series B of $34...
Crystal Pharmatech, a Suzhou-New Jersey materials science...
Adagene, a Suzhou BioBay antibody...
Deals and Financings
Apollomics, a Hangzhou...
CGene Tech, a Suzhou BioBay novel small...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China